Literature DB >> 9228265

Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis.

M Filippi1, T Yousry, M A Rocca, G Fesl, R Voltz, G Comi.   

Abstract

INTRODUCTION: We performed this study to define the sensitivity of delayed gadolinium-enhanced magnetic resonance imaging (MRI) in detecting active lesions in the brains of patients with multiple sclerosis (MS).
MATERIAL AND METHODS: T1-weighted images were obtained in 27 patients with relapsing-remitting or secondary progressive MS before, 5-7 min and 20-30 min after the injection of 0.1 mmol/kg gadolinium-DTPA.
RESULTS: One-hundred-and-three enhancing lesions were found on the early and 110 on the delayed scans (increase=6.4%). Six patients had 8 additional lesions in the delayed scans, while 1 patient had 1 more lesion on the early scan. Two of the 12 (17%) patients with no enhancing lesions on the early scans had 2 enhancing lesions on the delayed scans. The average increase of enhancing lesion detection with delayed scanning was 14.5% for those patients who already had enhancing lesions on the early post-contrast scans. A significant increase of the enhancing lesion volume was found with delayed scanning (P=0.004).
CONCLUSION: These data indicate that it is possible to increase MRI sensitivity in detecting MS active lesions by delaying the scanning after gadolinium injection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228265     DOI: 10.1111/j.1600-0404.1997.tb00220.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

2.  MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.

Authors:  Marc Saake; Soenke Langner; Carsten Schwenke; Marina Weibart; Olav Jansen; Norbert Hosten; Arnd Doerfler
Journal:  Eur Radiol       Date:  2015-06-30       Impact factor: 5.315

Review 3.  The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome.

Authors:  Robert Zivadinov; Milena Stosic; Jennifer L Cox; Deepa P Ramasamy; Michael G Dwyer
Journal:  J Neurol       Date:  2008-03       Impact factor: 4.849

4.  Feasibility of imaging myelin lesions in multiple sclerosis.

Authors:  Maria I Zavodszky; John F Graf; Cristina A Tan Hehir
Journal:  Int J Biomed Imaging       Date:  2011-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.